UpHealth (UPHL) Competitors $0.0002 0.00 (0.00%) As of 08/20/2025 03:07 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock UPHL vs. BTTX, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, and TALKWShould you be buying UpHealth stock or one of its competitors? The main competitors of UpHealth include Better Therapeutics (BTTX), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry. UpHealth vs. Its Competitors Better Therapeutics OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace UpHealth (NYSE:UPHL) and Better Therapeutics (NASDAQ:BTTX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Do insiders & institutionals have more ownership in UPHL or BTTX? 56.1% of UpHealth shares are held by institutional investors. Comparatively, 34.0% of Better Therapeutics shares are held by institutional investors. 34.2% of UpHealth shares are held by insiders. Comparatively, 51.4% of Better Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has more volatility and risk, UPHL or BTTX? UpHealth has a beta of 0.85, suggesting that its stock price is 15% less volatile than the S&P 500. Comparatively, Better Therapeutics has a beta of 0.97, suggesting that its stock price is 3% less volatile than the S&P 500. Is UPHL or BTTX more profitable? Company Net Margins Return on Equity Return on Assets UpHealthN/A N/A N/A Better Therapeutics N/A N/A N/A Which has stronger valuation & earnings, UPHL or BTTX? Better Therapeutics has lower revenue, but higher earnings than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpHealth$130M0.00-$56.42M-$1.350.00Better TherapeuticsN/AN/A-$39.76MN/AN/A Does the media prefer UPHL or BTTX? In the previous week, UpHealth's average media sentiment score of 0.00 equaled Better Therapeutics'average media sentiment score. Company Overall Sentiment UpHealth Neutral Better Therapeutics Neutral SummaryBetter Therapeutics beats UpHealth on 3 of the 5 factors compared between the two stocks. Get UpHealth News Delivered to You Automatically Sign up to receive the latest news and ratings for UPHL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding UPHL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart UPHL vs. The Competition Export to ExcelMetricUpHealthHealth services IndustryMedical SectorNYSE ExchangeMarket Cap$4K$70.71M$5.82B$21.16BDividend YieldN/AN/A3.84%3.59%P/E Ratio0.00N/A31.1529.14Price / Sales0.009.43474.7754.98Price / CashN/A4.0237.1523.84Price / Book0.001.159.115.45Net Income-$56.42M-$30.80M$3.26B$992.10M7 Day PerformanceN/A-14.61%2.12%2.62%1 Month PerformanceN/A-1.46%5.13%2.51%1 Year PerformanceN/A525.29%31.25%13.06% UpHealth Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)UPHLUpHealthN/A$0.00flatN/A-100.0%$4K$130M0.001,750BTTXBetter TherapeuticsN/A$0.00flatN/A+0.0%$5KN/A0.0040OPGNOpGenN/AN/AN/A-100.0%$1K$2.67M0.00100ACONWAclarionN/A$0.05+14.2%N/A+62.2%$0.00$54.60K0.007Gap UpAONCAmerican Oncology NetworkN/A$10.50-14.2%N/A+246.5%$0.00$1.34B0.001,520Gap DownDHACWDigital Health AcquisitionN/A$0.05-9.0%N/AN/A$0.00N/A0.00N/AFMSFresenius Medical Care AG & Co. KGaA2.8104 of 5 stars$24.86+2.7%$27.80+11.8%+32.8%$0.00$20.63B20.381,384News CoverageShort Interest ↑LFMDPLifeMDN/A$23.65+0.8%N/A+8.9%$0.00$245.56M0.00230Positive NewsOTRKPOntrakN/A$0.02flatN/A-90.1%$0.00$10.84M0.00250Gap UpHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01+4.0%N/A-55.9%$0.00$1.49B0.00500High Trading VolumeTALKWTalkspaceN/A$0.07+0.3%N/A+78.3%$0.00$202.61M0.00500Gap DownHigh Trading Volume Related Companies and Tools Related Companies BTTX Alternatives OPGN Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:UPHL) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredA grave, grave error.Nvidia just shattered records—hitting $4 trillion in valuation faster than any company in history. But one ...Porter & Company | SponsoredThe Tiny Stock Set to Soar with Musk's AI AmbitionsThe Tiny Stock Set to Soar with Musk's AI Ambitions While Musk builds one of the most ambitious AI empires ...Behind the Markets | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredLeaked Gov’t Memo Reveals $100 Trillion DeadlineOnly Days Left to Claim Your Share of Trump's $100T Play Trump's economic blueprint is about to go live, an...Stansberry Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UpHealth, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UpHealth With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access